Literature DB >> 4439869

Plasma levels of lidocaine during combined treatment with phenytoin and procainamide.

E Karlsson, P Collste, M D Rawlins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4439869     DOI： 10.1007/BF00560358

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  19 in total

1.  The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin.

Authors:  T C BUTLER
Journal:  J Pharmacol Exp Ther       Date:  1957-01       Impact factor: 4.030

Review 2.  Factors affecting drug metabolism.

Authors:  J R Gillette
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

3.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

4.  The effect of phenyramidol on the metabolism of diphenylhydantoin.

Authors:  H M Solomon; J J Schrogie
Journal:  Clin Pharmacol Ther       Date:  1967 Jul-Aug       Impact factor: 6.875

5.  Procainamide dosage schedules, plasma concentrations, and clinical effects.

Authors:  J Koch-Weser; S W Klein
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

6.  The determination of lidocaine and prilocaine in whole blood by gas chromatography.

Authors:  J B Keenaghan
Journal:  Anesthesiology       Date:  1968 Jan-Feb       Impact factor: 7.892

7.  Sinoatrial arrest: an interaction between phenytoin and lignocaine.

Authors:  R A Wood
Journal:  Br Med J       Date:  1971-03-20

8.  Metabolism of procainamide in rhesus monkey and man.

Authors:  J Dreyfuss; J T Bigger; A I Cohen; E C Schreiber
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

9.  Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.

Authors:  H Kutt; W Winters; F H McDowell
Journal:  Neurology       Date:  1966-06       Impact factor: 9.910

10.  Treatment of cardiac arrhythmias with phenytoin.

Authors:  J D Eddy; S P Singh
Journal:  Br Med J       Date:  1969-11-01
View more
  7 in total

Review 1.  Clinical pharmacokinetics of local anaesthetics.

Authors:  G T Tucker; L E Mather
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

Review 2.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

Review 3.  Interactions with antiepileptic drugs.

Authors:  A Richens
Journal:  Drugs       Date:  1977-04       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of procainamide.

Authors:  E Karlsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

Review 5.  Drug treatment of epilepsy: a review.

Authors:  D Rosenbloom; A R Upton
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

6.  Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

Review 7.  Tumescent Anesthesia for Dermatosurgical Procedures Other Than Liposuction.

Authors:  Ruhi R Uttamani; Aniketh Venkataram; Jayashree Venkataram; Venkataram Mysore
Journal:  J Cutan Aesthet Surg       Date:  2020 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.